Australia Sleep Apnea Devices Market, By Product (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks), By End User (Hospitals and Sleep Labs, Home Care), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 428.36 Million
CAGR (2026-2031)	7.84%
Fastest Growing Segment	Therapeutic Devices
Largest Market	ACT and New South Wales
Market Size (2031)	USD 673.73 Million

Market Overview

The Australia Sleep Apnea Devices Market will grow from USD 428.36 Million in 2025 to USD 673.73 Million by 2031 at a 7.84% CAGR. Sleep apnea devices are medical instruments designed to maintain open airways during sleep, thereby preventing breathing interruptions and enhancing oxygen flow, with common examples including Continuous Positive Airway Pressure machines and oral appliances. The Australia Sleep Apnea Devices Market is primarily driven by the increasing prevalence of sleep apnea and related disorders, coupled with growing public awareness of these conditions and their associated health risks. Furthermore, an aging population, which exhibits a higher incidence of sleep disorders, alongside rising healthcare expenditure and governmental initiatives aimed at promoting early diagnosis and treatment, collectively contribute to market expansion. According to a report released by the Network of Early Career Sleep Researchers in Training (NEST), a council of the Australasian Sleep Association (ASA), in April 2025, approximately 15% of Australians are potentially affected by obstructive sleep apnea.

However, the market faces a significant challenge due to the high initial costs associated with both diagnostic testing and sleep apnea devices, which can deter potential consumers. This cost barrier, coupled with limited accessibility, particularly in remote and rural regions where specialized clinics and adequate distribution networks are less developed, could impede broader market penetration and restrict overall growth.

Key Market Drivers

Rising prevalence expands the patient pool and demand for sleep apnea devices
The Australia Sleep Apnea Devices Market is significantly driven by the increasing prevalence of sleep apnea and related disorders across the Australian population. The growing recognition and diagnosis of these conditions expand the patient pool requiring therapeutic and diagnostic interventions. According to Sove CPAP Clinic in August 2025, obstructive sleep apnea affects roughly 20% of the Australian population, highlighting a substantial and expanding demographic in need of effective sleep management solutions. This rising prevalence directly correlates with an increased demand for devices designed to mitigate the health risks associated with untreated sleep apnea, such as cardiovascular disease and reduced quality of life.

Technological advances enhance comfort, efficacy, and adoption of sleep apnea devices
Another pivotal factor stimulating market growth is the continuous technological advancements in sleep apnea devices. Innovations focus on enhancing user comfort, device efficacy, and data integration, leading to improved patient adherence and outcomes. For instance, ResMed, on October 27, 2025, announced the launch of the AirTouch F30i Comfort in Australia, a new CPAP full face mask which subsequently earned Gold at the 2025 Australian Good Design Awards, demonstrating a commitment to advanced, user-friendly designs. These developments make therapy more appealing and effective for patients. Reflecting the positive impact of such innovations, Fisher & Paykel Healthcare reported for the 2026 financial year that revenue from obstructive sleep apnea masks was up 7%, according to HME News in May 2026.

Download Free Sample Report

Key Market Challenges

High Upfront Costs Hamper Diagnosis and Device Adoption
The Australia Sleep Apnea Devices Market faces a substantial challenge due to the high initial costs associated with both diagnostic testing and the specialized devices. This significant financial barrier directly deters potential consumers from pursuing necessary diagnosis and subsequent treatment. The considerable out-of-pocket expenses for polysomnography and continuous positive airway pressure (CPAP) machines, for instance, limit accessibility for many Australians, particularly those without comprehensive private health insurance. This directly curtails the adoption of sleep apnea devices, despite the increasing prevalence of the condition, as many affected individuals are unable to afford the required medical instruments.

Economic Burden of Inadequate Sleep and Device Costs
According to the Australasian Sleep Association and the Sleep Health Foundation's 2026-27 Pre-budget Submission, the direct financial cost of inadequate or poor quality sleep in Australia is currently estimated at AU$26.2 billion annually. This substantial economic burden on the nation, stemming partly from untreated sleep disorders like sleep apnea, demonstrates the widespread impact of financial constraints. High device costs contribute significantly to this burden, reducing overall market conversion and impeding the broader penetration and growth of the Australia Sleep Apnea Devices Market by limiting affordability and access for a critical segment of the population.

Key Market Trends

Expansion of HSAT and Improved Diagnostic Access in Australia
The proliferation of Home Sleep Apnea Testing (HSAT) is fundamentally transforming diagnostic pathways in Australia. This trend allows for convenient and cost-effective sleep studies outside traditional clinical settings, thereby improving patient accessibility, particularly in remote regions. HSAT devices enable individuals to undergo crucial diagnostic assessments from the comfort of their homes, reducing bottlenecks in sleep clinics and accelerating early detection rates. This shift is supported by strategic collaborations within the industry, such as Compumedics securing a five-year Somfit HSAT supply deal worth AU$15 million for Philips Australia's pharmacy channel in February 2025. This increased convenience and expanded reach are critical for addressing undiagnosed sleep apnea cases across the country.

AI and IoT-Driven Advancements in Sleep Apnea Devices
The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into sleep apnea devices represents another pivotal trend. These advanced technologies enhance device connectivity, enabling sophisticated remote monitoring, personalized therapy adjustments, and improved patient adherence. AI algorithms analyze data from connected devices to identify patterns, predict treatment needs, and offer tailored support, moving beyond basic data logging to proactive intervention. Reflecting the potential impact of these smart features, ResMed's 2026 Global Sleep Survey indicated that approximately two-thirds of wearable device users, 62%, would likely seek medical advice if their device suggested a risk of sleep apnea. This strong consumer inclination towards device-driven health insights highlights the growing significance of AI and IoT in the Australian market.

Segmental Insights

Drivers of Therapeutic Devices Growth in Australia’s Sleep Apnea Market
The Therapeutic Devices segment is experiencing rapid growth in the Australia Sleep Apnea Devices Market due to several interconnected factors. A significant and rising prevalence of sleep apnea, particularly Obstructive Sleep Apnea, among the adult population, driven by lifestyle factors such as increasing obesity rates, directly fuels the demand for sustained therapeutic interventions. Furthermore, continuous advancements in device technology, including more comfortable and intelligent Positive Airway Pressure machines, enhance patient adherence and broaden their adoption. Complementing this, expanding healthcare expenditure, increased insurance coverage, and government initiatives supporting sleep disorder treatments improve the accessibility and affordability of these devices, facilitating a shift towards effective home-based management of sleep apnea across Australia.

Regional Insights

ACT and NSW: Market leadership underpinned by robust healthcare infrastructure and favorable payer landscape
The Australian Capital Territory and New South Wales collectively lead the Australia Sleep Apnea Devices Market, primarily driven by their robust and advanced healthcare infrastructure. This region benefits from a high concentration of leading hospitals, academic medical centers, and extensive private specialist networks, which ensure comprehensive diagnostic and treatment capabilities. A significant presence of accredited sleep medicine practitioners and multidisciplinary clinics, supported by bodies like the Australasian Sleep Association, facilitates efficient patient pathways from initial assessment to therapeutic device prescription, resulting in improved treatment adherence. Furthermore, widespread public and private health insurance adoption, combined with higher average household incomes, enables greater investment in essential sleep apnea devices and long-term care.

Recent Developments

• In October 2025, ResMed introduced the AirTouch F30i Comfort mask in Australia. This new full-face mask was recognized with a Gold award at the Australian Good Design Awards, signifying its innovative design and potential benefits for users. The launch of this mask demonstrates ResMed's ongoing commitment to developing enhanced therapy solutions for the Australian sleep apnea devices market, focusing on improving patient comfort and adherence to continuous positive airway pressure (CPAP) therapy.
• In March 2025, Fisher & Paykel Healthcare Corporation Limited launched its F&P Nova Nasal mask in New Zealand and Australia. This new product expands the company's comprehensive portfolio of masks designed for treating obstructive sleep apnea (OSA). The F&P Nova Nasal mask integrates innovative technology focused on improving patient comfort and treatment outcomes, featuring an easy-to-use SwingFit™ headgear and a RollFit™ cushion for a stable seal. This launch reinforces Fisher & Paykel Healthcare's dedication to the Australian sleep apnea devices market.
• In February 2025, Compumedics Limited and Royal Philips NV expanded their collaboration in Australia to enhance the diagnosis of obstructive sleep apnea (OSA). Compumedics began supplying its Somfit devices and electrodes to Philips' established pharmacy-based sleep programs across the country. This partnership aims to simplify home-based sleep testing for Australian patients by utilizing the Somfit technology, which offers an easy-to-use electrode that connects to a mobile application for data transmission to healthcare professionals. This initiative specifically addresses the growing segment of pharmacy-based sleep diagnostics in the Australian sleep apnea devices market.
• In February 2025, Australian medical technology company Optalert unveiled a breakthrough test for sleep issues, designed for widespread accessibility within the Australian market. The innovative smartphone-based test, completed in approximately 10 minutes, detects subtle eyelid movements using the Apple iPhone's forward-facing camera and a proprietary algorithm. This method identifies signs of sleep issues by leveraging a unique biomarker related to impaired eyelid coordination due to reduced oxygen during sleep, offering a highly accurate, non-invasive screening tool.

Key Market Players

• ResMed Inc.
• Philips Healthcare
• Fisher & Paykel Healthcare Corporation Limited
• DeVilbiss Healthcare LLC
• Invacare Corporation
• SomnoMed Limited
• BMC Medical Co. Ltd.
• Drive DeVilbiss Healthcare
• Curative Medical Inc.
• Compumedics Limited

By Product	By End User	By Region
Diagnostic Devices Therapeutic Devices Sleep Apnea Masks	Hospitals and Sleep Labs Home Care	Australia Capital Territory & New South Wales Northern Territory & Southern Australia Western Australia Queensland Victoria & Tasmania

Report Scope:

In this report, the Australia Sleep Apnea Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Australia Sleep Apnea Devices Market, By Product:

• Diagnostic Devices
• Therapeutic Devices
• Sleep Apnea Masks

• Australia Sleep Apnea Devices Market, By End User:

• Hospitals and Sleep Labs
• Home Care

• Australia Sleep Apnea Devices Market, By Region:

• Australia Capital Territory & New South Wales
• Northern Territory & Southern Australia
• Western Australia
• Queensland
• Victoria & Tasmania